SuperGen Presentations at AACR-NCI-EORTC
|
|
|
| Posted
:
Mon, 09 Nov 2009 11:02:00 GMT |
| Author
:
SuperGen, Inc.
|
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
| Press Release
News |
Home
|
|
|
|
DUBLIN, Calif. - (Business Wire) SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of seven abstracts for poster presentations on November 16, 17 and 18, 2009 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, MA. SuperGen’s presentations will review clinical and non-clinical advances in the following compounds: MP-470, SGI-1776, SGI-110, SGI-1252, as well as two presentations on the Etk program. The posters will be made available for viewing on the company’s website www.supergen.com following the respective presentations. | MP-470: The tyrosine kinase inhibitor MP470 inhibits RAD51-mediated homologous recombination and increases tumor cell radio- and chemosensitivity | | Abstract A122, Monday Nov 16, 12:30 – 2:30 pm EST | | | | SGI-110: In vivo activity of SGI-110, a novel hypomethylating agent for treatment in hematology and solid malignancies | | Abstract A190, Monday Nov 16, 12:30 – 2:30 pm EST | | | | MP-470: A self-emulsifying lipid suspension formulation enhances oral bioavailability of MP-470 in a randomized two-way crossover study in healthy male subjects | | Abstract B209, Tuesday Nov 17, 12:30 – 2:30 pm EST | | | | SGI-1776: The novel PIM kinase inhibitor SGI-1776 significantly enhances the preclinical activity of sunitinib in renal cell carcinoma | | Abstract B272, Tuesday Nov 17, 12:30 – 2:30 pm EST | | | | ETK/BMX: Mechanistic, functional and in vivo efficacy of inhibiting ETK/BMX in cancer models | | Abstract B263, Tuesday Nov 17, 12:30 – 2:30 pm EST | | | | SGI-1252: In vivo activity of SGI-1252, a potent, small-molecule dual inhibitor of JAK2 and ALK2 | | Abstract C206, Wednesday Nov 18, 12:30 – 2:30 pm EST | | | | ETK: Development of potent, small-molecule inhibitors of ETK | | Abstract C199 Wednesday Nov 18, 12:30 – 2:30 pm EST | About SuperGen SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.
SuperGen, Inc.
Timothy L. Enns, 925-560-2810
Senior Vice President
Corporate Communications & Business Development
tenns@supergen.com
Susanna Chau, 925-560-2845
Manager
Investor Relations
schau@supergen.com
|
Copyright © 2008
Business Wire. All rights reserved.
|
|
|
|
|
Related
News
OKI Electric Cable Launches VEYOR-CABLE™ Smooth-Sliding Parallel Robot Cables
KANAGAWA, Japan -
OKI
Electric Cable (TOKYO:5815) today
Taipei Starts Countdown to 2010 Flora Expo
TAIPEI,Taiwan -
Taipei Mayor Hau Lung-bin announced on Nov. 6 the countdown of exactly
365 days to the opening of the 2010 Taipei International Gardening and
Horticulture Exposition and urged other cities and counties of Taiwan to
join Taipei City in putting Taiwan in the spotlight on the wo
Overstock.com Chairman and CEO Corrects Misstatements in Grant Thornton Letter to SEC
SALT LAKE CITY, Nov. 24 -- Overstock.com, Inc. (Nasdaq: OSTK) yesterday filed a Form 8-K/A which included a letter from the company's former auditor to the SEC. Below is a letter from Patrick Byrne, the company's Chairman and CEO, commenting on Grant Thornton...
EACOM Timber Corporation: Warrant Holders Exercise $2.4 Million of Warrants Early
VANCOUVER, BRITISH COLUMBIA -- 11/24/09 --
EACOM Timber Corporation (NEX: ETR.H) today announced it has received proceeds of $2,406,250 related to the early exercise of 9,625,000 warrants. These proceeds plus the Company's estimated $2 million in w..
Research and Markets: Asia Pacific Markets for Dental Implants and Final Abutments - Valued at Just Over US$480 Million in 2008
DUBLIN -
Research and Markets (
ILS Proton Successfully Launches the W7 Satellite for Eutelsat
BAIKONUR COSMODROME, Kazakhstan -
International Launch Services (ILS), a world leader in providing mission
and launch services to the commercial space industry, successfully
carried the W7 satellite to orbit for Eutelsat Communications of France
on an ILS Proton. The Proton vehicle lifted of
New Luxury Real Estate Listing for Judy Zeder and The Zeder Team - 9205 SW 58th Avenue
Judy Zeder is one of the most successful realtors in the country, ranking last year as one of the top ten residential realtors in Florida, and in the top one-half of one percent of realtors nationally. She is proud to present her latest luxury property listing here./I/P
P(PRWEB) Novembe...
|
|
|
|
|
|
|
|
|
